Innovative Diagnostic Laboratory (“IDL”) is a national clinical reference lab specializing in personalized blood-based testing to help find, understand, and address cancer risk in patient populations. IDL’s mission is to provide a comprehensive menu of traditional and advanced clinical evidence-based blood tests that aid in cancer risk stratification. Currently IDL offers risk assessment blood tests for the three most prevalent cancer types including lung, colon and prostate.  IDL is actively in-licensing and commercializing an array of DNA, RNA, protein and autoantibody blood-based cancer diagnostic tests to address early detection of all major types of cancer.   Patients Learn more about our convenient blood tests for cancer risk assessment. Physicians Create teachable moments and initiate testing before patients leave your office. Partners Improve cancer screening rates through patient-friendly testing.